D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$728M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$625M |
| 3 |
Merck
MRK
|
+$498M |
| 4 |
Bank of America
BAC
|
+$487M |
| 5 |
Fortinet
FTNT
|
+$321M |
Top Sells
| 1 |
Tesla
TSLA
|
+$696M |
| 2 |
Adobe
ADBE
|
+$610M |
| 3 |
Accenture
ACN
|
+$518M |
| 4 |
Microsoft
MSFT
|
+$495M |
| 5 |
Broadcom
AVGO
|
+$471M |
Sector Composition
| 1 | Technology | 22.95% |
| 2 | Consumer Discretionary | 14.11% |
| 3 | Healthcare | 10.4% |
| 4 | Financials | 9.83% |
| 5 | Industrials | 7.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Sight Sciences
SGHT
$181M
| $2.03M | ﹤0.01% |
321,587
-43,664
| -12% | -$275K |
|
1652
Winnebago Industries
WGO
$949M
| $2.02M | ﹤0.01% |
34,794
-46,034
| -57% | -$2.68M |
|
1653
Clean Harbors
CLH
$12.7B
| $2.02M | ﹤0.01% |
8,364
+834
| +11% | +$202K |
|
1654
BGC Group
BGC
$4.82B
| $2.01M | ﹤0.01% |
219,203
+187,182
| +585% | +$1.72M |
|
|
EURK
1655
Eureka Acquisition Corp Class A Ordinary Share
EURK
| $2.01M | ﹤0.01% |
+200,000
| New | +$2.01M |
|
1656
Patria Investments
PAX
$2.31B
| $2.01M | ﹤0.01% |
179,714
+20,963
| +13% | +$234K |
|
1657
Agilent Technologies
A
$34.9B
| $2M | ﹤0.01% |
13,464
+9,146
| +212% | +$1.36M |
|
1658
Ingles Markets
IMKTA
$1.32B
| $2M | ﹤0.01% |
26,786
+2,208
| +9% | +$165K |
|
1659
Day One Biopharmaceuticals
DAWN
$729M
| $1.99M | ﹤0.01% |
143,135
-81,205
| -36% | -$1.13M |
|
1660
Stitch Fix
SFIX
$714M
| $1.99M | ﹤0.01% |
704,824
-601,305
| -46% | -$1.7M |
|
|
VSTO
1661
DELISTED
Vista Outdoor Inc.
VSTO
| $1.98M | ﹤0.01% |
50,551
-7,982
| -14% | -$313K |
|
1662
BlueLinx
BXC
$617M
| $1.97M | ﹤0.01% |
18,713
+1,157
| +7% | +$122K |
|
1663
Gentex
GNTX
$6.25B
| $1.97M | ﹤0.01% |
+66,360
| New | +$1.97M |
|
1664
Johnson Controls International
JCI
$70.4B
| $1.96M | ﹤0.01% |
25,261
-131,209
| -84% | -$10.2M |
|
1665
B&G Foods
BGS
$360M
| $1.96M | ﹤0.01% |
220,719
+123,041
| +126% | +$1.09M |
|
1666
Kimball Electronics
KE
$741M
| $1.96M | ﹤0.01% |
105,859
-4,157
| -4% | -$76.9K |
|
1667
Sempra
SRE
$54.8B
| $1.95M | ﹤0.01% |
23,367
-41,606
| -64% | -$3.48M |
|
1668
International Flavors & Fragrances
IFF
$16.8B
| $1.95M | ﹤0.01% |
18,623
+12,165
| +188% | +$1.28M |
|
1669
Invesco
IVZ
$10B
| $1.95M | ﹤0.01% |
111,187
-524,504
| -83% | -$9.21M |
|
1670
PAR Technology
PAR
$1.79B
| $1.94M | ﹤0.01% |
+37,197
| New | +$1.94M |
|
1671
ImmunityBio
IBRX
$2.46B
| $1.93M | ﹤0.01% |
+520,053
| New | +$1.93M |
|
1672
Mersana Therapeutics
MRSN
$35.6M
| $1.93M | ﹤0.01% |
40,898
-17,725
| -30% | -$838K |
|
1673
Establishment Labs
ESTA
$1.09B
| $1.93M | ﹤0.01% |
+44,648
| New | +$1.93M |
|
1674
CTS Corp
CTS
$1.23B
| $1.93M | ﹤0.01% |
39,915
-100
| -0.2% | -$4.84K |
|
|
SVM
1675
Silvercorp Metals
SVM
$1.15B
| $1.92M | ﹤0.01% |
440,400
+104,100
| +31% | +$453K |
|